EP

Eversept Partners Portfolio holdings

AUM $1.78B
1-Year Est. Return 97.69%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+97.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.31B
AUM Growth
+$313M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
98
New
Increased
Reduced
Closed

Top Buys

1
+$65.2M
2
+$26.1M
3
+$15.9M
4
DHR icon
Danaher
DHR
+$15.1M
5
PODD icon
Insulet
PODD
+$14.3M

Top Sells

1
+$43.8M
2
+$21.3M
3
+$15.4M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$15.3M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$11.6M

Sector Composition

1 Healthcare 99.96%
2 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PNTG icon
76
Pennant Group
PNTG
$1.18B
$958K 0.07%
37,980
MRVI icon
77
Maravai LifeSciences
MRVI
$512M
$834K 0.06%
290,673
-350,000
PVLA
78
Palvella Therapeutics
PVLA
$1.99B
$711K 0.05%
+11,343
EHTH icon
79
eHealth
EHTH
$50.3M
$553K 0.04%
128,322
RVP icon
80
Retractable Technologies
RVP
$21.3M
$306K 0.02%
+363,315
REPL icon
81
Replimune Group
REPL
$680M
$251K 0.02%
+59,992
CBLL
82
CeriBell Inc
CBLL
$694M
$196K 0.02%
+17,094
DYN icon
83
Dyne Therapeutics
DYN
$3.26B
$127K 0.01%
+10,000
ACIU icon
84
AC Immune
ACIU
$306M
– –
-100,752
ARCT icon
85
Arcturus Therapeutics
ARCT
$217M
– –
-48,364
AUTL
86
Autolus Therapeutics
AUTL
$426M
– –
-610,231
GKOS icon
87
Glaukos
GKOS
$5.99B
– –
-31,496
GMED icon
88
Globus Medical
GMED
$11.7B
– –
-169,643
INSP icon
89
Inspire Medical Systems
INSP
$1.7B
– –
-164,473
IQV icon
90
IQVIA
IQV
$28.7B
– –
-97,604
ITOS
91
DELISTED
iTeos Therapeutics
ITOS
– –
-109,324
KPTI icon
92
Karyopharm Therapeutics
KPTI
$151M
– –
-257,154
MODV
93
DELISTED
ModivCare
MODV
– –
-100,000
PBYI icon
94
Puma Biotechnology
PBYI
$308M
– –
-240,688
PTGX icon
95
Protagonist Therapeutics
PTGX
$6.19B
– –
-277,316
QQQ icon
96
Invesco QQQ Trust
QQQ
$393B
– –
0
TMO icon
97
Thermo Fisher Scientific
TMO
$186B
– –
-13,685
ATYR
98
aTyr Pharma
ATYR
$91.7M
– –
0
1 2 3
4